BCL2 and B-cell acute lymphoblastic leukemia: In a panel of mouse leukemic cells engineered to be dependent on exogenously expressed human antiapoptotic BCL-2 family members45, ABBV-467 showed selective inhibition of the human MCL-1–expressing B-cell acute lymphoblastic leukemia variant (Supplementary Table S3).